The role of botulinum toxin injections in the management of muscle overactivity of the lower limb

Disability and Rehabilitation

Volumn 29, Issue 23, 2007, Pages 1789-1805

  Gracies, Jean Michel ^a   Singer, Barbara ^b   Dunne, John ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Botulinum toxin; Lower limb; Muscle overactivity; Spastic paresis

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; PLACEBO;

CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG UPTAKE; DRUG WITHDRAWAL; DYSTONIA; EDEMA; ELECTROMYOGRAPHY; ELECTROSTIMULATION THERAPY; FLU LIKE SYNDROME; FUNCTIONAL DISEASE; HUMAN; HYPERACTIVITY; INJECTION SITE; LEG DISEASE; LONG TERM CARE; LOW DRUG DOSE; MUSCLE CONTRACTION; MUSCLE CONTRACTURE; MUSCLE DISEASE; MUSCLE EXAMINATION; MUSCLE SPASM; MUSCLE STRETCHING; MUSCLE TRAINING; NERVE ENDING; NONHUMAN; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SAFETY; PATIENT SELECTION; PES EQUINOVARUS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SPASTIC PARESIS; SPLINTING; TREATMENT OUTCOME; WEAKNESS;

ANIMALS; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; ELECTROMYOGRAPHY; HUMANS; INJECTIONS, INTRAMUSCULAR; LEG; MUSCLE CONTRACTION; MUSCLE SPASTICITY; NEEDLES; RETREATMENT;

EID: 36549066890     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.1080/09638280701568437     Document Type: Review

References (205)

1. Gracies, J. M. (2005) Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve, 31:5, pp. 535-551.
2. Gracies, J. M. (2005) Pathophysiology of spastic paresis. II: Emergence of muscle overactivity. Muscle Nerve, 31:5, pp. 552-571.
3. Lance, J. W. (1980) Symposium synopsis. Spasticity: Disordered motor control, pp. 485-494. Year Book Medical, Chicago
4. Sheean, G. (2002) The pathophysiology of spasticity. Eur J Neurol, pp. 3-9.
5. Powers, R. K., Campbell, D. L. and Rymer, W. Z. (1989) Stretch reflex dynamics in spastic elbow flexor muscles. Ann Neurol, pp. 32-42.
6. Katz, R. T. and Rymer, W. Z. (1989) Spastic hypertonia: Mechanisms and measurement. Arch Phys Med Rehabil, 70:2, pp. 144-155.
7. Thilmann, A. F., Fellows, S. J. and Garms, E. (1991) The mechanism of spastic muscle hypertonus. Variation in reflex gain over the time course of spasticity. Brain, 114, pp. 233-244.
8. Landau, W. M. (2004) Spasticity after stroke: Why bother?. Stroke, 35:8, pp. 1787-1788.
9. Gracies, J. M. (2001) Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Phys Med Rehabil Clin N Am, 12:4, pp. 747-768.
10. Gracies, J. M., Elovic, E., McGuire, J. and Simpson, D. (2002) Traditional pharmacologic treatments of spasticity. Part 1. Local treatments. Spasticity: Etiology, evaluation, and the role of botulinum toxin, pp. 44-64. WE MOVE, New York
11. Gracies, J. M. (2004) Physiological effects of botulinum toxin in spasticity. Mov Disord, p. S120.
12. Dressler, D. and Benecke, R. (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehab, 29, pp. 1761-1768.
13. Coffield, J. A., Bakry, N., Zhang, R. D., Carlson, J., Gomella, L. G. and Simpson, L. L. (1997) In vitro characterization of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches. J Pharmacol Exp Ther, 280:3, pp. 1489-1498.
14. Aoki, K. R. and Guyer, B. (2001) Botulinum toxin type A and other botulinum toxin serotypes: A comparative review of biochemical and pharmacological actions. Eur J Neurol, 8, pp. 21-29.
15. Callaway, J. E. (2004) Botulinum toxin type B (Myobloc): Pharmacology and biochemistry. Clin Dermatol, 22:1, pp. 23-28.
16. Dolly, J. O. and Aoki, K. R. (2006) The structure and mode of action of different botulinum toxins. Eur J Neurol, pp. 1-9.
17. Turkel, C. C., Bowen, B., Liu, J. and Brin, M. F. (2006) Pooled analysis of the safety of Botulinum Toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil, 87, pp. 786-792.
18. Hughes, R. and Whaler, B. C. (1962) Influence of nerve ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Clostridium botulinum type A toxin. J Physiol, 160, pp. 221-223.
19. Eleopra, R., Tugnoli, V. and De Grandis, D. (1997) The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans. Mov Disord, 12, pp. 89-94.
20. Chen, R., Karp, B. I., Goldstein, S. R., Bara-Jimenez, W., Yaseen, Z. and Hallett, M. (1999) Effect of muscle activity immediately after botulinum toxin injection for writer's cramp. Mov Disord, 14, pp. 307-312.
21. Hesse, S., Jahnke, M. T., Luecke, D. and Mauritz, K. H. (1995) Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett, 201:1, pp. 37-40.
22. Bayram, S., Sivrioglu, K., Karli, N. and Ozcan, O. (2006) Low-dose botulinum toxin with short-term electrical stimulation in post-stroke spastic drop foot: A preliminary study. Am J Phys Med Rehabil, 85:1, pp. 75-81.
23. de Kroon, J. R., van der Lee, J. H., IJzerman, M. J. and Lankhorst, G. J. (2002) Therapeutic electrical stimulation to improve motor control and functional abilities of the upper extremity after stroke: A systematic review. Clin Rehabil, 16:4, pp. 350-360.
24. Bolton, D. A., Cauraugh, J. H. and Hausenblas, H. A. (2004) Electromyogram-triggered neuromuscular stimulation and stroke motor recovery of arm/hand functions: A meta-analysis. J Neurol Sci, 30223:2, pp. 121-127.
25. Pomeroy, V. M., King, L. M., Pollock, A., Baily-Hallam, A. and Langhorne, P. (2006) Electrostimulation for promoting recovery of movement or functional ability after Stroke. Systematic review and meta-analysis. Stroke, 37, pp. 2441-2442.
26. Manni, E., Bagolini, B., Pettorossi, V. E. and Errico, P. (1989) Effect of botulinum toxin on extraocular muscle proprioception. Doc Ophtalmol, 72, pp. 189-198.
27. Filippi, G. M., Errico, P., Santarelli, R., Bagolini, B. and Manni, E. (1993) Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol (Stockh), 113, pp. 400-404.
28. Rosales, R. L., Arimura, K., Takenaga, S. and Osame, M. (1996) Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve, 19, pp. 488-496.
29. Gracies, J. M., Wilson, L., Gandevia, S. C. and Burke, D. (1997) Stretched position of spastic muscles aggravates their co-contraction in hemiplegic patients. Ann Neurol, 42, pp. 438-439.
30. Proske, U., Morgan, D. L. and Gregory, J. E. (1993) Thixotropy in skeletal muscle and in muscle spindles: A review. Prog Neurobiol, 41:6, pp. 705-721.
31. Shaari, C. M., George, E., Wu, B. L., Biller, H. F. and Sanders, I. (1991) Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope, 101, pp. 960-964.
32. George, E. F., Zimbler, M., Wu, B. L., Biller, H. F. and Sanders, I. (1992) Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol, 101, pp. 888-892.
33. Girlanda, P., Vita, G., Nicolosi, C., Milone, S. and Messina, C. (1992) Botulinum toxin therapy: Distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psych, 55, pp. 844-845.
34. Solomon, B. A. and Hayman, R. (2000) Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol, 42, pp. 1026-1029.
35. Swartling, C., Farnstrand, C., Abt, G., Stalberg, E. and Naver, H. (2001) Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: A neurophysiological study. Eur J Neurol, 8, pp. 451-456.
36. Dressler, D. and Benecke, R. (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol, 49, pp. 34-38.
37. Pastor, A. M., Moreno-Lopez, B., De La Cruz, R. R. and Delgado-Garcia, J. M. (1997) Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: Ultrastructural and synaptic alterations. Neuroscience, 81, pp. 457-478.
38. Sanders, D. B., Massey, E. W. and Buckley, E. G. (1986) Botulinum toxin for blepharospasm: Single fiber EMG studies. Neurology, 36, pp. 545-547.
39. Lange, D. J., Brin, M. F., Warner, C. L., Fahn, S. and Lovelace, R. E. (1987) Distant effects of local injection of botulinum toxin. Muscle Nerve, 10, pp. 552-555.
40. Lange, D. J., Rubin, M., Greene, P. E., Kand, U. J., Moskowitz, C. B., Brin, M. F., Lovelace, R. E. and Fahn, S. (1991) Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes. Muscle Nerve, 41, pp. 672-675.
41. Olney, R. K., Aminoff, M. J., Gelb, D. J. and Lowenstein, D. H. (1988) Neuromuscular effects distant from the site of botulinum neurotoxin injection. Neurology, 38, pp. 1780-1783.
42. Wohlfarth, K., Schubert, M., Rothe, B., Elek, J. and Dengler, R. (2001) Remote F-wave changes after local botulinum toxin application. Clin Neurophysiol, 112:4, pp. 636-640.
43. Boroff, D. A. and Chen, G. S. (1975) On the question of permeability of the blood-brain barrier to botulinum toxin. Int Arch Allergy Appl Immunol, 48, pp. 495-504.
44. Wiegand, H., Erdmann, G. and Wellhoner, H. H. (1976) 125 I-labeled botulinum A neurotoxin: Pharmacokinetics in cats after neuromuscular injection. Naunyn Schmiedebergs Arch Pharmacol, 292, pp. 161-165.
45. Dolly, J. O., Williams, R. S., Black, J. D., Tse, C. K., Hambleton, P. and Melling, J. (1982) Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes. Toxiconology, 20, pp. 141-148.
46. Hagenah, R., Benecke, R. and Wiegand, H. (1977) Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurones. Naunyn Schmiedebergs Arch Pharmacol, 299, pp. 267-272.
47. Mikhailov, V. V. (1958) Electrophysiological analysis of disturbances in reflex activity of the spinal cord in experimental botulism. Bull Exp Biol Med, 46, pp. 1188-1192.
48. Mikhailov, V. V. and Barashkov, G. N. (1977) Mechanism of disorders of inhibition of electrogenesis in spinal alpha-motor neurons in experimental local botulin poisoning. Biull Eksp Biol Med, 83, pp. 651-654.
49. Moreno-Lopez, B., Pastor, A. M., de la Cruz, R. R. and Delgado-Garcia, J. M. (1997) Dose-dependent, central effects of botulinum neurotoxin type A: A pilot study in the alert behaving cat. Neurology, 48, pp. 456-464.
50. Wiegand, H. and Wellhoner, H. H. (1974) Proceedings: Type A botulinum toxin in cats: Neural ascent and action on spinal cord reflexes. Naunyn Schmiedebergs Arch Pharmacol, 282, p. R106.
51. Wiegand, H. and Wellhöner, H. H. (1977) The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol, 298, pp. 235-238.
52. Guyton, A. C. and McDonald, M. A. (1947) Physiology of botulinus toxin. Arch Neurol Psych, 57, pp. 578-592.
53. Mallart, A., Molgo, J., Angaut-Petit, D. and Thesleff, S. (1989) Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings?. Brain Res, 479, pp. 167-171.
54. Tyler, H. R. (1963) Physiological observations in human botulism. Arch Neurol, 9, pp. 661-670.
55. Gracies, J. M., Elovic, E., McGuire, J. and Simpson, D. M. (1997) Traditional pharmacological treatments for spasticity. Part I: Local treatments. Muscle Nerve Suppl., 6, p. S61.
56. Hultborn, H., Jankowska, E. and Lindstrom, S. (1971) Recurrent inhibition from motor axon collaterals of transmission in the Ia inhibitory pathway to motoneurones. J Physiol, 215, pp. 591-612.
57. Priori, A., Berardelli, A., Mercuri, B. and Manfredi, M. (1995) Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain, 118, pp. 801-807.
58. Modugno, N., Priori, A., Berardelli, A., Vacca, L., Mercuri, B. and Manfredi, M. (1998) Botulinum toxin restores presynaptic inhibition of group Ia afferents in patients with essential tremor. Muscle Nerve, 21:12, pp. 1701-1705.
59. Pauri, F., Boffa, L., Cassetta, E., Pasqualetti, P. and Rossini, P. M. (1999) Botulinum toxin type-A treatment in spasticity increases the central conduction time to brain stimulation. Electroencephalogr Clin Neurophysiol Suppl, 51, pp. 250-259.
60. Pauri, F., Boffa, L., Cassetta, E., Pasqualetti, P. and Rossini, P. M. (2000) Botulinum toxin type-A treatment in spastic paraparesis: A neurophysiological study. J Neurol Sci, 181, pp. 89-97.
61. Bischoff, C., Schoenle, P. W. and Conrad, B. (1992) Increased F-wave duration in patients with spasticity. Electromyogr Clin Neurophysiol, 32, pp. 449-453.
62. Hultborn, H. and Nielsen, J. B. (1996) Comments: Methodological problems of comparing F responses and H reflexes. Muscle Nerve, 19, pp. 1347-1348.
63. Hultborn, H. and Nielsen, J. B. (1995) H-reflexes and F-responses are not equally sensitive to changes in motoneuronal excitability. Muscle Nerve, 18, pp. 1471-1474.
64. Gelb, D. J., Yoshimura, D. M., Olney, R. K., Lowenstein, D. H. and Aminoff, M. J. (1991) Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol, 29, pp. 370-376.
65. Valls-Sole, J., Tolosa, E. S. and Ribera, G. (1991) Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psych, 54, pp. 310-313.
66. Behari, M. and Raju, G. B. (1996) Electrophysiological studies in patients with blepharospasm before and after botulinum toxin A therapy. J Neurol Sci, 135, pp. 74-77.
67. Girlanda, P., Quartarone, A., Sinicropi, S., Nicolosi, C. and Messina, C. (1996) Unilateral injection of botulinum toxin in blepharospasm: Single fiber electromyography and blink reflex study. Mov Disord, 11, pp. 27-31.
68. Valls-Sole, J., Tolosa, E. S., Marti, M. J. and Allam, N. (1994) Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystonia. Clin Neuropharmacol, 17, pp. 229-235.
69. Tardieu, G., Tardieu, C. and Hariga, J. (1971) Infiltrations with 45 degrees ethyl alcohol of the motor points, the roots by the epidural route, or of the posterior tibial nerve. Their indications and contra-indications in the various forms of spasticity (experience of 10 years). Rev Neurol (Paris), 125, pp. 63-68.
70. Tardieu, G. (1972) Troubles du maintien postural des membres supérieurs. Les Feuillets de l'Infirmité Motrice Cérébrale, Chapitre VB1f, pp. 1-10. Association Nationale des IMC Ed, Paris
71. Tardieu, G., Tardieu, C. and Hariga, J. (1972) Selective partial denervation by alcohol injections and their results in spasticity. Reconstr Surg Traumatol, 13, pp. 18-36.
72. McLellan, D. L. (1977) Co-contraction and stretch reflexes in spasticity during treatment with baclofen. J Neurol Neurosurg Psych, 40, pp. 30-38.
73. Knutsson, E. and Richards, C. (1979) Different types of disturbed motor control in gait of hemiparetic patients. Brain, 102, pp. 405-430.
74. Knutsson, E. and Martensson, A. (1980) Dynamic motor capacity in spastic paresis and its relation to prime mover dysfunction, spastic reflexes and antagonist co-activation. Scand J Rehabil Med, 12, pp. 93-106.
75. Hammond, M. C., Fitts, S. S., Kraft, G. H., Nutter, P. B., Trotter, M. J. and Robinson, L. M. (1988) Co-contraction in the hemiparetic forearm: Quantitative EMG evaluation. Arch Phys Med Rehabil, 69, pp. 348-351.
76. Wing, A. M., Lough, S., Turton, A., Fraser, C. and Jenner, J. R. (1990) Recovery of elbow function in voluntary positioning of the hand following hemiplegia due to stroke. J Neurol Neurosurg Psych, 53, pp. 126-134.
77. Levin, M. F. and Hui-Chan, C. (1994) Ankle spasticity is inversely correlated with antagonist voluntary contraction in hemiparetic subjects. Electromyogr Clin Neurophysiol, 34, pp. 415-425.
78. Levin, M. F. (1996) Interjoint coordination during pointing movements is disrupted in spastic hemiparesis. Brain, 119, pp. 281-293.
79. Levin, M. F., Selles, R. W., Verheul, M. H. and Meijer, O. G. (2000) Deficits in the coordination of agonist and antagonist muscles in stroke patients: Implications for normal motor control. Brain Res, 853, pp. 352-369.
80. 2 cost of walking in children with cerebral palsy. Med Sci Sports Exerc, 28, pp. 1498-1504.
81. Unnithan, V. B., Dowling, J. J., Frost, G., Ayub, B Volpe and Bar-Or, O. (1996) Cocontraction and phasic activity during GAIT in children with cerebral palsy. Electromyogr Clin Neurophysiol, 36, pp. 487-494.
82. Dewald, J. P., Pope, P. S., Given, J. D., Buchanan, T. S. and Rymer, W. Z. (1995) Abnormal muscle coactivation patterns during isometric torque generation at the elbow and shoulder in hemiparetic subjects. Brain, 118, pp. 495-510.
83. Levin, M. F. and Dimov, M. (1997) Spatial zones for muscle coactivation and the control of postural stability. Brain Res, 757, pp. 43-59.
84. Hubley-Kozey, C. and Earl, E. M. (2000) Coactivation of the ankle musculature during maximal isokinetic dorsiflexion at different angular velocities. Eur J Appl Physiol, 82:4, p. 289.
85. Croce, R. V. and Miller, J. P. (2006) Coactivation patterns of the medial and lateral hamstrings based on joint position and movement velocity during isokinetic movements. Electromyogr Clin Neurophysiol, 46:2, pp. 113-122.
86. Kamper, D. G. and Rymer, W. Z. (2001) Impairment of voluntary control of finger motion following stroke: Role of inappropriate muscle coactivation. Muscle Nerve, 24:5, pp. 673-681.
87. Gracies, J. M., Weitz, D. J., Yang, B. Y., Flanagan, S. and Simpson, D. (2001) Evidence for increased antagonist strength and movement speed following botulinum toxin injections in spasticity. Neurology, 56, p. A3.
88. Nielsen, J. and Kagamihara, Y. (1992) The regulation of disynaptic reciprocal Ia inhibition during co-contraction of antagonistic muscles in man. J Physiol, 456, pp. 373-391.
89. Nielsen, J. and Kagamihara, Y. (1993) The regulation of presynaptic inhibition during co-contraction of antagonistic muscles in man. J Physiol, 464, pp. 575-593.
90. Nielsen, J., Sinkjaer, T., Toft, E. and Kagamihara, Y. (1994) Segmental reflexes and ankle joint stiffness during co-contraction of antagonistic ankle muscles in man. Exp Brain Res, 102, pp. 350-358.
91. Llewellyn, M., Yang, J. F. and Prochazka, A. (1990) Human H-reflexes are smaller in difficult beam walking than in normal treadmill walking. Exp Brain Res, 83, pp. 22-28.
92. Nielsen, J., Nagaoka, M., Kagamihara, Y., Kakuda, N. and Tanaka, R. (1994) Discharge of muscle afferents during voluntary co-contraction of antagonistic ankle muscles in man. Neurosci Lett, 170, pp. 277-280.
93. Nielsen, J. and Pierrot-Deseilligny, E. (1996) Evidence of facilitation of soleus-coupled Renshaw cells during voluntary co-contraction of antagonistic ankle muscles in man. J Physiol, 493, pp. 603-611.
94. Farmer, S. F., Harrison, L. M., Ingram, D. A. and Stephens, J. A. (1991) Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology, 41, pp. 1505-1510.
95. Katz, R. and Pierrot-Deseilligny, E. (1982) Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions. Brain, 105, pp. 103-124.
96. Crone, C., Nielsen, J., Petersen, N., Ballegaard, M. and Hultborn, H. (1994) Disynaptic reciprocal inhibition of ankle extensors in spastic patients. Brain, 117, pp. 1161-1168.
97. Nakashima, K., Rothwell, J. C., Day, B. L., Thompson, P. D., Shannon, K. and Marsden, C. D. (1989) Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke. Brain, 112, pp. 681-697.
98. Faist, M., Mazevet, D., Dietz, V. and Pierrot-Deseilligny, E. (1994) A quantitative assessment of presynaptic inhibition of Ia afferents in spastics. Differences in hemiplegics and paraplegics. Brain, 117, pp. 1449-1455.
99. Nielsen, J., Petersen, N. and Crone, C. (1995) Changes in transmission across synapses of Ia afferents in spastic patients. Brain, 118, pp. 995-1004.
100. Morita, H., Crone, C., Christenhuis, D., Petersen, N. T. and Nielsen, J. B. (2001) Modulation of presynaptic inhibition and disynaptic reciprocal Ia inhibition during voluntary movement in spasticity. Brain, 124, pp. 826-837.
101. Hamjian, J. A. and Walker, F. O. (1994) Serial neurophysiological studies of intramuscular botulinum-A toxin in humans. Muscle Nerve, 17, pp. 1385-1392.
102. Hagenah, R. (1979) Neuropharmacologic and neurotoxic studies on the Renshaw mechanism. Fortschr Med, 97:41, pp. 1840-1844.
103. Hesse, S., Brandl-Hesse, B., Seidel, U., Doll, B. and Gregoric, M. (2000) Lower limb muscle activity in ambulatory children with cerebral palsy before and after the treatment with Botulinum toxin A. Restor Neurol Neurosci, 17, pp. 1-8.
104. Heinen, F., Molenaers, G., Fairhurst, C., Carr, L. J., Desloovere, K., Valayer, E Chaleat, Morel, E., Papavassiliou, A. S., Tedroff, K., Pascual-Pascual, S Ignacio, Bernert, G., Berweck, S., Rosa, G Di, Kolanowski, E. and Krageloh-Mann, I. (2006) European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol, 10:5, pp. 215-225.
105. Gibson, N., Graham, H. K. and Love, S. (2007) Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy. Disabil Rehab, 29, pp. 1813-1822.
106. Denny-Brown, D. (1966) The cerebral control of movement, pp. 124-143. Liverpool University Press, Liverpool, UK
107. Tardieu, G. (1969) Description classique et étude critique des cinq formes d'infirmité motrice cerébrale internationalement retenues. Classifications diverses Les Feuillets de l'Infirmité Motrice Cérébrale, pp. 1-8. Association Nationale des IMC Ed, Paris
108. Lance, J. W. and McLeod, J. G. (1981) A physiological approach to clinical neurology, p. 145. Butterworths, London
109. Burke, D. (1975) An approach to the treatment of spasticity. Drugs, 10, pp. 112-120.
110. Burke, D. (1988) Spasticity as an adaptation to pyramidal tract injury. Adv Neurol, 47, pp. 401-423.
111. Young, R. R. (1994) Spasticity: A review. Neurology, 44, p. S12.
112. Ada, L., O'Dwyer, N. and O'Neill, E. (2006) Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: An observational study. Disabil Rehabil, 28:13, pp. 891-897.
113. Baker, J. H. and Hall-Craggs, E. C. (1978) Changes in length of sarcomeres following tenotomy of the rat soleus muscle. Anat Rec, 192, pp. 55-58.
114. Baker, J. H. and Hall-Craggs, E. C. (1980) Changes in sarcomere length following tenotomy in the rat. Muscle Nerve, 3, pp. 413-416.
115. McLachlan, E. M. (1981) Rapid atrophy of mouse soleus muscles after tenotomy depends on an intact innervation. Neurosci Lett, 25, pp. 269-274.
116. McLachlan, E. M. (1983) Modification of the atrophic effects of tenotomy on mouse soleus muscles by various hind limb nerve lesions and different levels of voluntary motor activity. Exp Neurol, 81, pp. 669-682.
117. McLachlan, E. M. (1983) Atrophic effects of proximal tendon transection with and without denervation on mouse soleus muscles. Exp Neurol, 81, pp. 651-668.
118. McLachlan, E. M. and Chua, M. (1983) Rapid adjustment of sarcomere length in tenotomized muscles depends on an intact innervation. Neurosci Lett, 35, pp. 127-133.
119. Booth, F. W. and Seider, M. J. (1979) Early change in skeletal muscle protein synthesis after limb immobilization of rats. J Appl Physiol, 47, pp. 974-977.
120. Booth, F. W. (1982) Effect of limb immobilization on skeletal muscle. J Appl Physiol, 52, pp. 1113-1118.
121. Williams, P. E. and Goldspink, G. (1984) Connective tissue changes in immobilised muscle. J Anat, 138, pp. 343-350.
122. Tabary, J. C., Tabary, C., Tardieu, C., Tardieu, G. and Goldspink, G. (1972) Physiological and structural changes in cat's soleus muscle due to immobilization at different lengths by plaster casts. J Physiol (Lond), 224, pp. 231-244.
123. Tardieu, C., Tardieu, G., Colbeau-Justin, P., de la Tour, E Huet and Lespargot, A. (1979) Trophic muscle regulation in children with congenital cerebral lesions. J Neurol Sci, 42, pp. 357-364.
124. Ranson, S. W. and Dixon, H. H. (1928) Elasticity and ductility of muscle in myostatic contracture caused by tetanus toxin. Am J Physiol, 86, pp. 312-319.
125. Pollock, L. J. and Davis, L. (1930) Studies in decerebration. VI. The effect of deafferentation upon decerebrate rigidity. Am J Physiol, 98, pp. 47-49.
126. de la Tour, E Huet, Tardieu, C., Tabary, J. C. and Tabary, C. (1979) Decrease of muscle extensibility and reduction of sarcomere number in soleus muscle following a local injection of tetanus toxin. J Neurol Sci, 40, pp. 123-131.
127. Tabary, J. C., Tardieu, C., Tardieu, G. and Tabary, C. (1981) Experimental rapid sarcomere loss with concomitant hypoextensibility. Muscle Nerve, 4:3, pp. 198-203.
128. Cosgrove, A. P. and Graham, H. K. (1994) Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse. Dev Med Child Neurol, 36, pp. 379-385.
129. Corry, I. S., Cosgrove, A. P., Walsh, E. G., McClean, D. and Graham, H. K. (1997) Botulinum toxin A in the hemiplegic upper limb: A double-blind trial. Dev Med Child Neurol, 39:3, pp. 185-193.
130. Corry, I. S., Cosgrove, A. P., Duffy, C. M., McNeill, S., Taylor, T. C. and Graham, H. K. (1998) Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: A randomised prospective trial. J Pediatr Orthop, 18, pp. 304-311.
131. Thompson, N. S., Baker, R. J., Cosgrove, A. P., Corry, I. S. and Graham, H. K. (1998) Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait. Dev Med Child Neurol, 40, pp. 622-625.
132. Eames, N. W., Baker, R., Hill, N., Graham, K., Taylor, T. and Cosgrove, A. (1999) The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response. Dev Med Child Neurol, 41:4, pp. 226-232.
133. Cosgrove, A. P., Corry, I. S. and Graham, H. K. (1994) Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol, 36, pp. 386-396.
134. Koman, L. A., Mooney III, J. F., Smith, B. P., Walker, F. and Leon, J. M. (2000) Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group. J Pediatr Orthop, 20, pp. 108-115.
135. Flett, P. J., Stern, L. M., Waddy, H., Connell, T. M., Seeger, J. D. and Gibson, S. K. (1999) Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health, 35:1, pp. 71-77.
136. Bang, M. S., Chung, S. G., Kim, S. B. and Kim, S. J. (2002) Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy. Am J Phys Med Rehabil, 81:10, pp. 760-764.
137. Polak, F., Morton, R., Ward, C., Wallace, W. A., Doderlein, L. and Siebel, A. (2002) Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy. Dev Med Child Neurol, 44:8, pp. 551-555.
138. Scott, A. B. (1984) Injection treatment of endocrine orbital myopathy. Doc Ophthalmol, 58, pp. 141-145.
139. Scott, A. B. (1994) Change of eye muscle sarcomeres according to eye position. J Pediatr Ophthalmol Strabismus, 31, pp. 85-88.
140. Scott, A. B. and Kraft, S. P. (1985) Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology, 92, pp. 676-683.
141. Kowal, L., Wong, E. and Yahalom, C. (2007) Botulinum toxin in the treatment of strabismus: A review of its use and effects. Disabil Rehab, 29, pp. 1823-1831.
142. Bakheit, A. M. (2004) Optimising the methods of evaluation of the effectiveness of botulinum toxin treatment of post-stroke muscle spasticity. J Neurol Neurosurg Psych, 75:5, pp. 665-666.
143. Turner-Stokes, L. and Ashford, S. (2007) Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb. Disabil Rehab, 29, pp. 1806-1812.
144. Snow, B. J., Tsui, J. K., Bhatt, M. H., Varelas, M., Hashimoto, S. A. and Calne, D. B. (1990) Treatment of spasticity with botulinum toxin: A double-blind study. Ann Neurol, 28:4, pp. 512-515.
145. Dunne, J. W., Heye, N. and Dunne, S. L. (1995) Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psych, 58:2, pp. 232-235.
146. Grazko, M. A., Polo, K. B. and Jabbari, B. (1995) Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology, 45:4, pp. 712-717.
147. Hesse, S., Krajnik, J., Luecke, D., Jahnke, M. T., Gregoric, M. and Mauritz, K. H. (1996) Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke, 27:3, pp. 455-460.
148. Burbaud, P., Wiart, L., Dubos, J. L., Gaujard, E., Debelleix, X., Joseph, P. A., Mazaux, J. M., Bioulac, B., Barat, M. and Lagueny, A. (1996) A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psych, 61:3, pp. 265-269.
149. Kirazli, Y., On, A. Y., Kismali, B. and Aksit, R. (1998) Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial. Am J Phys Med Rehabil, 77:6, pp. 510-515.
150. Hyman, N., Barnes, M., Bhakta, B., Cozens, A., Bakheit, M., Kreczy-Kleedorfer, B., Poewe, W., Wissel, J., Bain, P., Glickman, S., Sayer, A., Richardson, A. and Dott, C. (2000) Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psych, 68:6, pp. 707-712.
151. Richardson, D., Sheean, G., Werring, D., Desai, M., Edwards, S., Greenwood, R. and Thompson, A. (2000) Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psych, 69:4, pp. 499-506.
152. Pittock, S. J., Moore, A. P., Hardiman, O., Ehler, E., Kovac, M., Bojakowski, J., Khawaja, I Al, Brozman, M., Kanovsky, P., Skorometz, A., Slawek, J., Reichel, G., Stenner, A., Timerbaeva, S., Stelmasiak, Z., Zifko, U. A., Bhakta, B. and Coxon, E. (2003) A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis, 15:4, pp. 289-300.
153. Fock, J., Galea, M. P., Stillman, B. C., Rawicki, B. and Clark, M. (2004) Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Inj, 18:1, pp. 57-63.
154. Johnson, C. A., Burridge, J. H., Strike, P. W., Wood, D. E. and Swain, I. D. (2004) The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: A preliminary investigation. Arch Phys Med Rehabil, 85:6, pp. 902-909.
155. Rousseaux, M., Compere, S., Launay, M. J. and Kozlowski, O. (2005) Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles. J Neurol Sci, 15232:1, pp. 51-57.
156. Mancini, F., Sandrini, G., Moglia, A., Nappi, G. and Pacchetti, C. (2005) A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurol Sci, 26:1, pp. 26-31.
157. Cioni, M., Esquenazi, A. and Hirai, B. (2006) Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot. Am J Phys Med Rehabil, 85:7, pp. 600-606.
158. Bergfeldt, U., Borg, K., Kullander, K. and Julin, P. (2006) Focal spasticity therapy with botulinum toxin: Effects on function, activities of daily living and pain in 100 adult patients. J Rehabil Med, 38:3, pp. 166-171.
159. Verplancke, D., Snape, S., Salisbury, C. F., Jones, P. W. and Ward, A. B. (2005) A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil, 19:2, pp. 117-125.
160. Molteni, F. (1995) Botulinum toxin and rehabilitation programs in lower limb spasticity. Eur J Neurol, 2, pp. 61-67.
161. Reiter, F., Danni, M., Lagalla, G., Ceravolo, G. and Provinciali, L. (1998) Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil, 79, pp. 532-535.
162. Hesse, S., Werner, C., Bardeleben, A. and Brandl-Hesse, B. (2002) Management of upper and lower limb sposticity in neuro-rehabilitation. Acta Neurochir Suppl., 79, pp. 117-122.
163. Houltram, J., Noble, I., Boyd, R. N., Corry, I., Flett, P. and Graham, H. K. (2001) Botulinum toxin type A in the management of equinus in children with cerebral palsy: An evidence-based economic evaluation. Eur J Neurol, 8, pp. 194-202.
164. Booth, M. Y., Yates, C. C., Edgar, T. S. and Bandy, W. D. (2003) Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther, 15:4, pp. 216-220.
165. Bottos, M., Benedetti, M. G., Salucci, P., Gasparroni, V. and Giannini, S. (2003) Botulinum toxin with and without casting in ambulant children with spastic diplegia: A clinical and functional assessment. Dev Med Child Neurol, 45:11, pp. 758-762.
166. Glanzman, A. M., Kim, H., Swaminathan, K. and Beck, T. (2004) Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: A retrospective analysis. Dev Med Child Neurol, 46:12, pp. 807-811.
167. Ackman, J. D., Russman, B. S., Thomas, S. S., Buckon, C. E., Sussman, M. D., Masso, P., Sanders, J., D'Astous, J., Aiona, M. D. and Shriners Hospitals BTX-A Study Group (2005) Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol, 47:9, pp. 620-627.
168. Kay, R. M., Rethlefsen, S. A., Fern-Buneo, A., Wren, T. A. and Skaggs, D. L. (2004) Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am, 86:11, pp. 2377-2384.
169. Wemove Spasticity Study Group (2002) Spasticity: Etiology, evaluation, management and the role of botulinum toxin
170. Robertson, A., Ashford, S., Heward, K., Katchburian, L., Kent, R., O'Brein, P., Power, T. and Wiggins, L. (2006) The role of physiotherapists in the management of spasticity in adults and paediatric patients: A consensus guideline, ConnectMedical. Mededdlum Group Pty Ltd.
171. Das-Gupta, R. and Turner-Stokes, L. (2002) Traumatic brain injury. Disabil Rehabil, 24:13, pp. 654-665.
172. Fanucci, E., Masala, S., Squillaci, E., Sodani, G., Varrucciu, V., Ursone, A. and Simonetti, G. (2003) Pyriformis muscle syndrome: CT/MR
173. Haig, A. J., Goodmurphy, C. W., Harris, A. R., Ruiz, A. P. and Etemad, J. (2003) The accuracy of needle placement in lower-limb muscles: A blinded study. Arch Phys Med Rehabil, 84, pp. 877-882.
174. Childers, M. K. (2003) The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Phys Med Rehabil Clin N Am, 14:4, pp. 781-792.
175. Childers, M. K. (2004) Targeting the neuromuscular junction in skeletal muscles. Am J Phys Med Rehabil, 83:10, p. S38.
176. Geenan, C., Consky, E. and Ashby, P. (1996) Localising muscles for botulinum toxin treatment of focal dystonia. Can J Neurol Sci, 23, pp. 194-197.
177. Schroeder, A. S., Berweck, S., Lee, S. H. and Heinen, F. (2006) Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques. Neurotox Res, 9:2, pp. 189-196.
178. Childers, M. K., Kornegay, J. N., Aoki, R., Otaviani, L., Bogan, D. J. and Petroski, G. (1998) Evaluating motor end-plate-targeted injections of botulinum toxin type A in a canine model. Muscle Nerve, 21:5, pp. 653-655.
179. Gracies, J. M., Hefter, H., Simpson, D. M. and Moore, P. (2003) Spasticity in adults. Handbook of Botulinum toxin treatment, pp. 219-269. Blackwell Science, Mass, USA
180. WHO (2001) International classification of function, disability and health, World Health Organization, Geneva
181. Gracies, J. M., Marosszeky, J. E., Renton, R., Sandanam, J., Gandevia, S. C. and Burke, D. (2000) Short-term effects of dynamic lycra splints on upper limb in hemiplegic patients. Arch Phys Med Rehabil, 81:12, pp. 1547-1555.
182. Harvey, L. A. and Herbert, R. D. (2002) Muscle stretching for treatment and prevention of contracture in people with spinal cord injury. Spinal Cord, 40:1, pp. 1-9.
183. Harvey, L. A., Batty, J., Crosbie, J., Poulter, S. and Herbert, R. D. (2000) A randomized trial assessing the effects of 4 weeks of daily stretching on ankle mobility in patients with spinal cord injuries. Arch Phys Med Rehabil, 81, pp. 1340-1347.
184. Harvey, L. A., Byak, A. J., Ostrovskaya, M., Glinsky, J., Katte, L. and Herbert, R. D. (2003) Randomised trial of the effects of four weeks of daily stretch on extensibility of hamstring muscles in people with spinal cord injuries. Aust J Physiother, 49, pp. 176-181.
185. Ben, M., Harvey, L., Denis, S., Glinsky, J., Goehl, G., Chee, S. and Herbert, R. D. (2005) Does 12 weeks of regular standing prevent loss of ankle mobility and bone mineral density in people with recent spinal cord injuries?. Aust J Physiother, 51:4, pp. 251-256.
186. Mortenson, P. A. and Eng, J. J. (2003) The use of casts in the management of joint mobility and hypertonia following brain injury in adults: A systematic review. Phys Ther, 83:7, pp. 648-658.
187. Singer, B. J., Dunne, J. W., Singer, K. P., Jegasothy, G. M. and Allison, G. T. (2004) Non-surgical management of ankle contracture following acquired brain injury. Disabil Rehabil, 26:6, pp. 335-345.
188. Singer, B. J., Jegasothy, G. M., Singer, K. P. and Allison, G. T. (2003) Evaluation of serial casting to correct equinovarus deformity of the ankle after acquired brain injury in adults. Arch Phys Med Rehabil, 84:4, pp. 483-491.
189. Jacobs, P. L. and Nash, M. S. (2001) Modes, benefits, and risks of voluntary and electrically induced exercise in persons with spinal cord injury. J Spinal Cord Med, 24:1, pp. 10-18.
190. Morris, S. L. (2004) Outcomes of progressive resistance strength training following stroke: A systematic review. Clin Rehabil, 18:1, pp. 27-39.
191. White, L. J., McCoy, S. C., Castellano, V., Gutierrez, G., Stevens, J. E. and Walter, G. A. (2004) Vandenborne. Resistance training improves strength and functional capacity in persons with multiple sclerosis. Mult Scler, 10:6, pp. 668-674.
192. Patten, C., Lexell, J. and Brown, H. E. (2004) Weakness and strength training in persons with post-stroke hemiplegia: Rationale, method, and efficacy. J Rehabil Res Dev, 41:3, pp. 293-312.
193. Gutierrez, G. M., Chow, J. W., Tillman, M. D., McCoy, S. C., Castellano, V. and White, L. J. (2005) Resistance training improves gait kinematics in persons with multiple sclerosis. Arch Phys Med Rehabil, 86:9, pp. 1824-1829.
194. Ada, L., Dorsch, S. and Canning, C. (2006) Strengthening interventions increase strength and improve activity after stroke: A systematic review. Aust J Physio, 52, pp. 241-248.
195. Taylor, N. F., Dodd, K. J., Prasad, D. and Denisenko, S. (2006) Progressive resistive exercise for people with multiple sclerosis. Disabil Rehabil, 28:18, pp. 1119-1126.
196. Ryan, A. S., Dobrovolny, C. L., Smith, G. V., Silver, K. H. and Macko, R. F. (2002) Hemiparetic muscle atrophy and increased intramuscular fat in stroke patients. Arch Phys Med Rehabil, 83, pp. 1703-1707.
197. Ada, L., Canning, C. G. and Low, S. L. (2003) Stroke patients have selective muscle weakness in shortened range. Brain, 126, pp. 724-731.
198. Koo, T. K., Mak, A. F., Hung, L. K. and Dewald, J. P. (2003) Joint position dependence of weakness during maximum isometric voluntary contraction in subjects with hemiparesis. Arch Phys Med Rehabil, 84, pp. 1380-1386.
199. Canning, C. G., Shepherd, R. B., Carr, J. H., Alison, J. A., Wade, L. and White, A. (2003) A randomized controlled trial of the effects of intensive sit-to-stand training after recent traumatic brain injury on sit-to-stand performance. Clin Rehabil, 17:4, pp. 355-362.
200. Moseley, A. M., Stark, A., Cameron, I. D. and Pollock, A. (2005) Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev, 19:4
201. Macko, R. F., Ivey, F. M. and Forrester, L. W. (2005) Task-oriented aerobic exercise in chronic hemiparetic stroke: Training protocols and treatment effects. Top Stroke Rehabil, 12:1, pp. 45-57.
202. Macko, R. F., Ivey, F. M., Forrester, L. W., Hanley, D., Sorkin, J. D., Katzel, L. I., Silver, K. H. and Goldberg, A. P. (2005) Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: A randomized, controlled trial. Stroke, 36:10, pp. 2206-2211.
203. Peurala, S. H., Tarkka, I. M., Pitkanen, K. and Sivenius, J. (2005) The effectiveness of body weight-supported gait training and floor walking in patients with chronic stroke. Arch Phys Med Rehabil, 86:8, pp. 1557-1564.
204. Sheean, G. L. (2001) Botulinum treatment of spasticity: Why is it so difficult to show a functional benefit?. Curr Opin Neurol, 14:6, pp. 771-776.
205. Sheean, G. (2006) Botulinum toxin treatment of adult spasticity: A benefit-risk assessment. Drug Saf, 29:1, pp. 31-48.